Replies to post #173176 on Amarin Corp Plc (AMRN)

[rosemountbomber]

I have had exactly the same thoughts. I mean at first all that was required alongside the Anchor data was that R-I was to be substantially enrolled. Then of course that changed to R-I being finished. So it seems they have all they need.

The only caveat is that the label now might be different. Anchor simply was to expand use of V to lower trigs in the >200mg population whereas now we are looking at concrete proof of cardiovascular benefits and risk lowering and not just trig lowering. My understanding could be wrong so willing to hear corrections to this.